Each trial has a specific set of criteria that potential participants must meet to qualify as a participant. Analyses will be intention-to-treat , consisting of all patients who have consented and have been randomised to a treatment arm. Safety analyses will include patients who have received at least one dose of study treatment. The primary efficacy endpoint will be overall survival (OS – time to event).

mesothelioma clinical trial

Talk to your doctor about whether a clinical trial is right for you. The purpose of this study is to evaluate the challenges, behavioral patterns, and preferences of minority patient participation in clinical trials. Also, to develop and validate a personalized clinical trial educational platform to boost participation among underserved cancer patients. For over 20 years we’ve provided the best FREE resources to mesothelioma patients and loved ones. Luis Argote-Greene is an internationally recognized thoracic surgeon. He has trained and worked with some of the most prominently known thoracic surgeons in the United States and Mexico, including pioneering mesothelioma surgeon Dr. David Sugarbaker.

Friends, Family & Other Mesothelioma Patients

Patients with malignant pleural mesothelioma that cannot be surgically removed will receive first-line treatment with standard chemotherapy of cisplatin or carboplatin and pemetrexed. Two-thirds of the participants in the study will be randomly assigned to also receive a new treatment called durvalumab. Durvalumab is an antibody that works by blocking a body substance called Programmed mesothelioma law firm Death-Ligand 1 (PD-L1). Research has shown that durvalumab can slow tumor growth and shrink tumors in some people with cancer. Previous studies of combining durvalumab and chemotherapy showed that this combination is active in advanced mesothelioma. The purpose of this study is to see whether adding durvalumab to standard chemotherapy will improve overall survival in patients with MPM.

mesothelioma clinical trial

Active, recruiting clinical trials accept mesothelioma cancer patients who meet certain eligibility criteria. Doctors can help interested patients understand eligibility and enrollment. This trial studies how well the addition of targeted radiation therapy to surgery and the usual chemotherapy treatment works for the treatment of stage I-IIIA malignant pleural mesothelioma. Not all patients will find success during a . However, every patient in a clinical trial receives, at minimum, the current standard of care.

The 4 Phases Of A Clinical Trial

This isn’t the norm, but there is hope that joining a clinical trial could add years to your life. In a clinical trial involving healthy patients, the control group might receive a placebo, which is an inactive version of the treatment. Many of these expenses are often covered by health insurance, depending on the patient’s policy. Some states have laws or special agreements that require health insurance companies to pay for routine care received in a clinical trial.

mesothelioma clinical trial

Food and Drug Administration to help fight solid cancers like glioblastoma and melanoma. When the vaccine is injected into the tumor, it tricks the body into recognizing the cancer as foreign and prompts white blood cells and antibodies to kill it. Both conventional and experimental treatments are provided measle thelioma in clinical trials. For example, some trials test new combinations of conventional treatments, while others test entirely new therapies. Conventional treatments for mesothelioma, such as surgery, chemotherapy and radiation therapy, may be combined with new treatments such as immunotherapy and gene therapy.

By Poster

Leave a Reply

Your email address will not be published.